Xsolis Ranks for 3rd Consecutive Year on the Inc. 5000
Xsolis listed among America's fastest-growing private companies from 2022-2024
"We are proud to be listed on the Inc. 5000 for the third year, among some of the nation's most preeminent entrepreneurial businesses," said
By harnessing the power of data and artificial intelligence, Xsolis meets the healthcare industry's growing demands for more data-driven decision making and seamless payer-provider data-sharing via its AI platform, Dragonfly. The platform synthesizes relevant clinical and financial data from patients' electronic health record, enabling the creation of a real-time clinical profile that is continuously evaluated against a vast database of situationally relevant cases.
The AI platform was relaunched from CORTEX® to Dragonfly in late 2023 and has made over 2.7 billion predictions to date, saving customers over
"As a leader in our use of AI in healthcare since the company's founding in 2013, the last couple of years have brought more understanding and excitement about the adoption of AI in healthcare," said Butters. "What sets Xsolis apart is our leadership and tenure in an increasingly competitive field and our solid track record with our clients."
For complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, location, and other criteria, go to www.inc.com/inc5000.
About Xsolis
Xsolis is an AI-driven technology company with a human-centered approach, fostering collaboration between healthcare providers and payers through real-time transparency, objective data for increased accuracy and alignment of medical necessity decisions, and more efficient outcomes. Dragonfly®, its AI-driven proprietary platform, is the first and only solution to use real-time predictive analytics to continuously assign an objective medical necessity score and assess the anticipated level of care for every patient, enabling more efficiency across the healthcare system. Xsolis is headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/xsolis-ranks-for-3rd-consecutive-year-on-the-inc-5000-302220682.html
SOURCE Xsolis
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BOA Acquisition Corp. II Announces Pricing of $125 Million Initial Public Offering
- Robinson Pharma Announces Major Expansion with New Facility in Irvine, California
- Greenberg Traurig Advises Cartesian Growth Corporation II on $1.2B Go-Public Merger with InoBat
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share